Explore Global Mofy AI Limited's February 2025 Form 6-K report detailing share issuance and warrant exercises, including a significant reverse stock split and outstanding shares.
Genmab A/S's Form 6-K reveals a capital increase from employee warrant exercises, ensuring SEC compliance. Key insights include filing details and executive signatures.
Explore SRIVARU Holding Ltd's 6-K filing, detailing a legal claim by Sabby Fund over warrant valuations. Understand potential impacts on operations and investor sentiment.
Explore LM Funding America's Amendment No. 1 to Form 8-K, detailing a significant Warrant Exercise Agreement, financial impacts, and compliance actions.
Explore Evaxion Biotech A/S's January 2025 Form 6-K filing revealing a DKK 11.47M share capital increase and warrant exercises. Key details on compliance and growth strategies.
Discover WEBUY GLOBAL LTD's latest Form 6-K report detailing a significant securities offering and warrant exercises, resulting in 71.3 million outstanding shares as of January 2025.
Explore SEALSQ Corp's latest Form 6-K report detailing warrant exercises, capital strategies, and SEC compliance measures, dated January 2, 2025.
Explore Ascendis Pharma A/S's December 2024 financial report detailing warrant exercises, capital structure changes, and share issuance impacts on shareholders.